HTL-STREFA is a world-leading medical device company that develops, manufactures and sells safety lancets, personal lancets, and pen needles for insulin injection. Our modern manufacturing process and nearly 20 years of experience on the global market allows us to successfully ensure safety and convenience. We employ a continuous improvement strategy to analyze and update products, implementing improvements and launching new solutions to meet the changing needs of both patients and health care professionals. The design of our products is defined by ergonomics, simplicity and reliability. At the moment, the Company has two modern production facilities in Poland, as well as two sales and marketing offices located in Warsaw (Poland) and Marietta (GA, USA). HTL-STREFA products are used in various diagnostic tests performed by hospitals, clinics, and laboratories. The company also produces personal lancets used by diabetics as well as disposable pen needles for insulin injections, compatible with most pens available worldwide. HTL-STREFA products and their patented technology have been developed for patients, as well as their comfort and ease of use. The company is constantly investing in research and development. Its team of engineers is always striving to create new solutions for patients and medical personnel, as well as innovative manufacturing technologies on a large scale to reduce the costs of supplied medical devices. Every day, nearly 10 million products are shipped from HTL-STREFA plants. Thanks to the highly developed distribution network, safety lancets, personal lancets, and insulin pen needles carrying the HTL-STREFA logo, or under our CustomerÕs brand, can be in all continents. HTL-STREFA is a brand with global experience from more than 80 countries, producing more than 50% of safety lancets worldwide. For years, our brand has been fulfilling the promises made to patients and health professionals, and has never failed.